EXANE DERIVATIVES - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 182 filers reported holding PTC THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$481,000
-89.9%
12
-90.6%
0.00%
-100.0%
Q1 2022$4,775,000
-26.0%
128
-21.0%
0.00%
-50.0%
Q4 2021$6,452,000
-86.7%
162
-87.5%
0.00%
-83.3%
Q3 2021$48,371,000
-29.6%
1,300
-17.8%
0.01%
-25.0%
Q2 2021$68,689,000
-8.3%
1,5820.0%0.02%
-23.8%
Q1 2021$74,904,000
-22.4%
1,5820.0%0.02%
-25.0%
Q4 2020$96,545,000
-42.5%
1,582
-55.9%
0.03%
-42.9%
Q3 2020$167,870,000
+95.7%
3,591
+112.4%
0.05%
+113.0%
Q2 2020$85,796,000
+13.7%
1,6910.0%0.02%
+9.5%
Q1 2020$75,432,000
-24.6%
1,691
-12.9%
0.02%
+10.5%
Q4 2019$99,980,0001,9420.02%
Other shareholders
PTC THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Ayer Capital Management, LP 416,666$7,153,00038.92%
Novo Holdings A/S 747,359$11,210,0002.78%
Bain Capital Public Equity Management, LLC 2,333,333$50,073,0001.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 845,027$18,134,0000.84%
HealthCor Management, L.P. 732,200$15,713,0000.84%
RA Capital Management 300,000$6,438,0000.67%
Catalyst Capital Advisors LLC 30,666$658,0000.36%
CR Intrinsic Investors, LLC 119,237$2,559,0000.08%
Weiss Multi-Strategy Advisers LLC 284,130$6,098,0000.07%
SECTORAL ASSET MANAGEMENT INC 57,519$1,234,0000.06%
View complete list of PTC THERAPEUTICS INC shareholders